Targeting specific gut bacteria and their metabolites could offer new ways to prevent or treat cardiovascular disease linked to diet and gut health.
Gianfranco Grompone, scientific director at BioGaia, explored innovative strategies for developing next-generation probiotics, with a focus on Limosilactobacillus reuteri DSM 17938.
Emmanuel Perrin, Advanced Technology Ingredients Senior Director Danone, explores Danone’s vision for harnessing the microbiome to guide the next generation of nutrition solutions.
Maintaining healthy T cells is key to preserving gut health and preventing chronic inflammation that drives aging-related diseases.
By revealing that OTUD3 limits microbiota-driven STING activation, the findings of a new study offer insights into the disease mechanisms of ulcerative colitis and may pave the way to new…
Jan Knol, Senior Director Research & Innovation at Danone Nutricia Research, discusses about the present and the future of microbiome research.
For Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, the message is clear: how we feed and protect our microbiome determines the clinical outcome.
Industry
Sponsored by
ProBeautyShield by SynBalance is an innovative probiotic complex developed to support and protect skin health.
Industry
Sponsored by
Taking the synbiotic mixture for three months appeared to boost the body’s metabolism and mitigates some of the main symptoms of post-COVID fatigue syndrome.
Engineered bacteria can be used in gut therapies, but maintaining control over their colonization and genetic stability remains challenging.
